| __timestamp | Amgen Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 11768000 |
| Thursday, January 1, 2015 | 4070000000 | 15152000 |
| Friday, January 1, 2016 | 3840000000 | 19828000 |
| Sunday, January 1, 2017 | 3562000000 | 25573000 |
| Monday, January 1, 2018 | 3737000000 | 23634000 |
| Tuesday, January 1, 2019 | 4116000000 | 38845000 |
| Wednesday, January 1, 2020 | 4207000000 | 50523000 |
| Friday, January 1, 2021 | 4819000000 | 75463000 |
| Saturday, January 1, 2022 | 4434000000 | 105767000 |
| Sunday, January 1, 2023 | 4784000000 | 167512000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Amgen Inc. and Xenon Pharmaceuticals Inc. have showcased contrasting strategies in their R&D investments. Amgen, a titan in the industry, consistently allocated substantial resources, with a peak in 2021, spending nearly 5 billion dollars. This represents a steady increase of about 10% from 2014. In contrast, Xenon Pharmaceuticals, a smaller player, has shown a remarkable growth trajectory, increasing its R&D spending by over 1,300% from 2014 to 2023. This surge underscores Xenon's commitment to innovation and its potential to disrupt the market. As we look to the future, these spending patterns highlight the diverse approaches companies take to secure their place in the ever-evolving biotech landscape.
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Comparing Innovation Spending: Amgen Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amgen Inc. vs HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Amgen Inc. vs Taro Pharmaceutical Industries Ltd.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.